HD-OPM Archive
Topics › Infections & vaccines

Shingrix linked to 24% lower dementia risk in over 500,000 Medicare recipients

Louis Nervegna · Aug 28, 2026 · ♥ 7 reactions · 0 comments · original Facebook post
Infections & vaccinesBrain health & dementia
AI summary & key facts

Louis shares another study linking the shingles vaccine to lower dementia risk, notable because it examined the newer Shingrix rather than Zostavax. Brown University researchers analyzed records of more than 500,000 Medicare recipients aged 66+ and reported 24% lower dementia risk over four years among vaccinated people.

Yet another study links the shingles vaccine with lower risk of dementia. This one was just published.

What is notable about this particular study is that it analyzed the newer shingles vaccine Shingrix, whereas previous studies mostly focused on the older vaccine Zostavax.

Link to journal paper:

Paper · Ann Intern Med · 2026Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stayacpjournals.org

Link to press release & media coverage:

Brown UniversityStudy suggests shingles vaccine may lower dementia riskA study led by Brown University researchers found that older adults who received the shingles vaccine currently used in the U.S. were less likely to be diagnosed with dementia within four years.brown.edu ScienceDailyShingles vaccine linked to 24% lower dementia riskOlder adults who received the Shingrix shingles vaccine were 24% less likely to be diagnosed with dementia over four years in a study of more than 500,000 people. Researchers estimate the difference could amount to roughly one dementia case prevented for every 17 people vaccinated.sciencedaily.com

#shinglesHD #vaccinesHD #dementiaHD #alzheimersHD #shingrixHD

Research cited

BONUS PROTECTION: The shingles vaccine has been linked to a 24% lower risk of dementia in older adults over a four-year period.

Brown University researchers analyzed health records of more than 500,000 Medicare recipients aged 66 and older and found those who received at least one dose of Shingrix saw a significant reduction in cognitive decline compared to unvaccinated individuals.

A clinical neurologist says this is the third or fourth study to reach the same conclusion — calling the finding "icing on the cake" atop a growing body of evidence.

➡ Full story here:

Fox NewsCommon vaccine linked to 24% lower dementia risk in older adultsA Brown University study found Shingrix reduced dementia risk by 24% over four years, building on prior research linking the shingles vaccine to brain health.foxnews.comMay be an image of text that says 'l D Лpлa VEOX FOX NEWS digital COMMON VACCINE LINKED TO 24% DROP IN DEMENTIA RISK'
← newer: FDA approves tirzepatide for CV risk reduction in type 2 diaolder: Case report: atorvastatin caused fully reversible hearing lo →